Dr Faridi is a mid-career Victorian Cancer Agency fellow, Head of the Translational Antigen Discovery Laboratory and the Director of the Clinical Proteomics Facility at the School of Clinical Sciences, Monash University. After completing his pharmacy doctorate and PhD at the Shiraz University of Medical Sciences (Iran), he joined Prof Ruedi Aebersold’s laboratory at Institute for Molecular Systems Biology at the ETH Zurich (Switzerland). In 2016, he moved to Australia and joined Prof Tony Purcell’s laboratory at Biomedicine Discovery Institute, Monash University. In 2021, he established his laboratory at the Department of Medicine, Monash University. Dr Faridi has developed mass spectrometry and proteomics technologies to identify and quantify peptides, proteins, and metabolites. He has applied these technologies to identify and validate actionable targets for cancer immunotherapy. Some of the peptides he identified are currently used for cancer vaccination clinical studies.